Aristotle Capital Boston’s Patterson-UTI PTEN Stock Holding History

Aristotle Capital Boston’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,181,281	Closed	-$6.12M	–	130
2025 Q3	$6.12M	Sell	1,181,281 -33,291	-3%	-$191K	0.32%	98
2025 Q2	$7.2M	Sell	1,214,572 -59,585	-5%	-$359K	0.37%	88
2025 Q1	$10.5M	Sell	1,274,157 -387,861	-23%	-$3.25M	0.52%	76
2024 Q4	$13.7M	Sell	1,662,018 -243,740	-13%	-$1.96M	0.51%	77
2024 Q3	$14.6M	Sell	1,905,758 -37,988	-2%	-$350K	0.48%	76
2024 Q2	$20.1M	Buy	1,943,746 +284,689	+17%	+$3.12M	0.68%	59
2024 Q1	$19.8M	Sell	1,659,057 -46,253	-3%	-$514K	0.6%	69
2023 Q4	$18.4M	Sell	1,705,310 -869,076	-34%	-$10.6M	0.56%	77
2023 Q3	$35.6M	Buy	+2,574,386	New	+$37.7M	1.15%	25

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aristotle Capital Boston's PTEN Position: Q4 2025 in Review

Aristotle Capital Boston sold out of Patterson-UTI (PTEN) in Q4 2025, closing a stake of 1,181,281 shares — an estimated $6.12M sold.

Aristotle Capital Boston first reported a position in PTEN in Q3 2023 and held it in 9 quarters. The position peaked at $35.6M in Q3 2023. 372 funds tracked by Wall St. Rank hold PTEN as of Q4 2025.

Aristotle Capital Boston reported no remaining Patterson-UTI position as of Q4 2025 after selling out during the quarter.
Aristotle Capital Boston sold 1,181,281 Patterson-UTI shares in Q4 2025, an estimated $6.12M.
Aristotle Capital Boston first reported a position in Patterson-UTI in Q3 2023 and held it in 9 quarters.
Aristotle Capital Boston's Patterson-UTI position peaked at $35.6M in Q3 2023.
372 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2025.

Based on Aristotle Capital Boston's 13F filing for Q4 2025, filed 17 Feb 2026.